Lotus Pharmaceutical Co., Ltd. (TPE: 1795)

Lotus Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	67,757	71,935	64,462	25,569	19,628	27,958
Market Cap Growth	-3.83%	11.59%	152.11%	30.27%	-29.79%	58.40%
Enterprise Value	75,569	81,666	71,660	30,851	25,397	34,043
Last Close Price	255.50	267.14	238.79	93.27	76.28	109.65
PE Ratio	16.73	17.05	20.69	17.05	18.08	40.02
PS Ratio	3.95	4.24	4.41	2.02	1.83	2.91
PB Ratio	3.66	4.15	4.65	2.31	2.24	3.62
P/FCF Ratio	18.65	59.76	20.51	-56.44	12.79	323.08
P/OCF Ratio	20.15	44.56	17.33	213.68	10.07	66.57
EV/Sales Ratio	4.46	4.82	4.90	2.44	2.37	3.54
EV/EBITDA Ratio	12.75	13.23	14.07	9.63	10.74	18.62
EV/EBIT Ratio	16.10	16.07	16.86	12.20	14.59	24.12
EV/FCF Ratio	20.80	67.85	22.81	-68.09	16.55	393.40
Debt / Equity Ratio	0.58	0.67	0.64	0.63	0.78	0.95
Debt / EBITDA Ratio	1.80	1.84	1.72	2.12	2.80	3.85
Debt / FCF Ratio	2.94	9.62	2.84	-15.33	4.45	84.92
Asset Turnover	0.51	0.54	0.58	0.62	0.57	0.58
Inventory Turnover	1.99	2.13	2.13	2.65	3.45	4.15
Quick Ratio	1.51	1.85	1.17	1.16	0.88	1.19
Current Ratio	2.16	2.80	1.81	1.93	1.39	1.85
Return on Equity (ROE)	23.68%	26.32%	24.23%	14.17%	12.48%	8.81%
Return on Assets (ROA)	8.85%	10.16%	10.47%	7.71%	5.73%	5.34%
Return on Capital (ROIC)	10.54%	12.29%	13.02%	9.41%	7.10%	6.41%
Earnings Yield	5.98%	5.71%	4.69%	5.49%	5.23%	2.37%
FCF Yield	5.36%	1.67%	4.87%	-1.77%	7.82%	0.31%
Dividend Yield	1.84%	1.74%	1.45%	2.07%	0.46%	-
Payout Ratio	22.58%	22.07%	16.75%	6.56%	-	-
Buyback Yield / Dilution	-0.40%	-0.13%	-1.95%	-5.43%	-0.65%	-1.55%
Total Shareholder Return	1.44%	1.61%	-0.50%	-3.36%	-0.19%	-1.55%

Source: S&P Capital IQ. Standard template. Financial Sources.